SHASHANK BHATT: Open Payments
NPI 1023189818 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,659 in 155 payments from 31 companies in 2025. Trend: 2023 $2,281 · 2024 $2,549 · 2025 $2,659
Food & beverage: $2,659
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $291 |
| Novo Nordisk Inc | 18 | $275 |
| ABBVIE INC. | 17 | $274 |
| Lilly USA, LLC | 15 | $263 |
| SHIELD THERAPEUTICS INC | 11 | $179 |
| GlaxoSmithKline, LLC. | 7 | $155 |
| AstraZeneca Pharmaceuticals LP | 3 | $135 |
| Exact Sciences Corporation | 6 | $124 |
| Sumitomo Pharma America, Inc. | 7 | $120 |
| Amgen Inc. | 7 | $107 |
Products named: ACCRUFER, Ozempic, JARDIANCE, NURTEC ODT, TRELEGY ELLIPTA, MOUNJARO, Cologuard Collection Kit, GEMTESA.
Industry payments across NY — which companies pay providers there.
